Researchers have developed a groundbreaking blood test using artificial intelligence that can predict Parkinson’s disease up to seven years before symptoms appear. This test, designed to be compatible with existing NHS lab equipment, could be available within two years pending further validation. While no current drugs can protect the brain from Parkinson’s, an accurate predictive test could identify individuals for clinical trials of disease-slowing treatments. The test was created using a machine learning algorithm to identify a signature pattern of eight blood proteins in Parkinson’s patients, successfully predicting future cases. Parkinson’s, the fastest-growing neurodegenerative condition globally, affects over 150,000 people in the UK and 10 million worldwide. Early diagnosis could enable earlier intervention with potential neuroprotective therapies, although challenges remain, including ethical concerns and the need for effective treatments. The test’s development represents a significant step toward better managing and potentially slowing the progression of Parkinson’s disease.

AI Blood Test Predicts Parkinson’s Years Before Symptoms Emerge
AI-powered blood test predicts Parkinson’s up to seven years in advance.
1–2 minutes










